In March 2020, Valid Insight brought together a panel of global payers and industry representatives to talk about how the COVID-19 pandemic may affect global market access. Now, 6 months on, we review what global changes have occurred, and discuss how these changes may have profound market access implications in the future, along with solutions to future-proof.

Join us and our esteemed speaker panel, consisting of:

  • Sue Caleo-Naeyaert: Former Global Head Government Affairs, Policy and Pharmacoeconomics at Fresenius Kabi SwissBioSim
  • Prof. Fabrizio Gianfrate: Professor of Health Economics. Former AIFA member and Director of the Ministry of Health
  • Leslie Galloway: Expert Adviser at the NICE Centre for Clinical Practice and Chairman of the Ethical Medicines Industry Group (EMIG)

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.